Visudyne blev desuden undersøgt i to år hos 120 patienter med subfoveal koroidal neovaskularisering forårsaget af patologisk nærsynethed.
Visudyne has also been studied for two years in 120 patients with subfoveal choroidal neovascularisation caused by pathologic myopia.